Live Breaking News & Updates on Nasdaq Akya

Stay updated with breaking news from Nasdaq akya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kent Lake Capital LLC Sells 629,686 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA)

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […] ....

United States , Brian Mckelligon , Akoya Biosciences , Asia Pacific , Blackrock Inc , Unisuper Management Pty Ltd , Kennedy Capital Management , Kent Lake Capital , Canaccord Genuity Group , Akoya Biosciences Inc , Peddock Capital Advisors , Jpmorgan Chase Co , Holdings Channel , Free Report , Lake Capital , Water Life Science Advisors , Super Management Pty Ltd , Capital Management , Capital Advisors , Get Free Report , North America , Middle East , Visit Holdingschannel , Akoya Biosciences Daily , Nasdaq Akya , Sec Filings ,

Akoya Biosciences Announces Preliminary Financial Results

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced. ....

Brian Mckelligon , Akoya Bioscience , Priyam Shah , Akoya Biosciences , Spatial Biology Company , Exchange Commission , Akoya Biosciences Inc , Chief Executive Officer , Financial Condition , Nasdaq Akya , Akoya Biosciences ,

Insider Selling: Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells 7,500 Shares of Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $4.48, for a total value of $33,600.00. Following the completion of the transaction, the chief executive officer now owns 152,563 shares […] ....

United States , Asia Pacific , Brian Mckelligon , Piper Sandler , Akoya Biosciences , Morgan Stanley , Charles Schwab Investment Management Inc , Akoya Biosciences Company Profile , American International Group Inc , Investment Counsel Inc , Jpmorgan Chase Co , Akoya Biosciences Inc , Get Free Report , International Group , Schwab Investment Management , North America , Middle East , Akoya Biosciences Daily , Nasdaq Akya , Insider Trading , Nsider Trades ,

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares of Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of Akoya Biosciences stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $4.48, for a total transaction of $33,600.00. Following the transaction, the chief executive officer now owns 152,563 shares in the company, […] ....

United States , Brian Mckelligon , Akoya Biosciences , Piper Sandler , Asia Pacific , Akoya Biosciences Inc , Akoya Biosciences Company Profile , Morgan Stanley , Peddock Capital Advisors , Unisuper Management Pty Ltd , Get Free Report , Capital Advisors , Capital Management , Water Life Science Advisors , Super Management Pty Ltd , North America , Middle East , Akoya Biosciences Daily , Nasdaq Akya , Insider Trading , Nsider Trades ,